Mesenchymal stem cells induce apoptosis of activated T cells (original) (raw)

References

1. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284: 143–147.
   Article CAS Google Scholar
2. Prockop DJ . Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997; 276: 71–74.
   Article CAS Google Scholar
3. Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM . Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 2001; 98: 2396–2402.
   Article CAS Google Scholar
4. Koc ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI et al. Rapid hematopoietic recovery after coinfusion of autologous-blood stem cells and culture-expanded marrow mesenchymal stem cells in advanced breast cancer patients receiving high-dose chemotherapy. J Clin Oncol 2000; 18: 307–316.
   Article CAS Google Scholar
5. Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, McNall RY et al. Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci USA 2002; 99: 8932–8937.
   Article CAS Google Scholar
6. Chamberlain JR, Schwarze U, Wang PR, Hirata RK, Hankenson KD, Pace JM et al. Gene targeting in stem cells from individuals with osteogenesis imperfecta. Science 2004; 303: 1198–1201.
   Article CAS Google Scholar
7. Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M et al. Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 2004; 363: 1439–1441.
   Article Google Scholar
8. Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 2002; 30: 42–48.
   Article Google Scholar
9. Di Nicola M, Carlo-Stella C, Magni M, Milanesi M, Longoni PD, Matteucci P et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 2002; 99: 3838–3843.
   Article CAS Google Scholar
10. Krampera M, Glennie S, Dyson J, Scott D, Laylor R, Simpson E et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide. Blood 2003; 101: 3722–3729.
    Article CAS Google Scholar
11. Djouad F, Plence P, Bony C, Tropel P, Apparailly F, Sany J et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood 2003; 102: 3837–3844.
    Article CAS Google Scholar
12. Le Blanc K, Tammik C, Rosendahl K, Zetterberg E, Ringden O . HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. Exp Hematol 2003; 31: 890–896.
    Article CAS Google Scholar
13. Tse WT, Pendleton JD, Beyer WM, Egalka MC, Guinan EC . Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation. Transplantation 2003; 75: 389–397.
    Article CAS Google Scholar
14. Moriscot C, de Fraipont F, Richard MJ, Marchand M, Savatier P, Bosco D et al. Human bone marrow mesenchymal stem cells can express insulin and key transcription factors of the endocrine pancreas developmental pathway upon genetic and/or microenvironmental manipulation in vitro. Stem cell 2005; 23: 594–603.
    Article CAS Google Scholar
15. Manches O, Lui G, Chaperot L, Gressin R, Molens J, Jacob M et al. In vitro mechanisms of action of rituximab on primary non-Hodgkin's lymphomas. Blood 2003; 101: 949–954.
    Article CAS Google Scholar
16. Lajmanovich A, Irisarri M, Molens JP, Pasquier MA, Sotto JJ, Bensa JC et al. Impairment of death-inducing signalling complex formation in CD95-resistant human primary lymphoma B cells. Br J Haematol 2004; 124: 746–753.
    Article CAS Google Scholar
17. Guillaudeux T, Rodriguez AM, Girr M, Mallet V, Ellis SA, Sargent IL et al. Methylation status and transcriptional expression of the MHC class I loci in human trophoblast cells from term placenta. J Immunol 1995; 154: 3283–3299.
    CAS PubMed Google Scholar
18. Fallarino F, Grohmann U, Vacca C, Bianchi R, Orabona C, Spreca A et al. T cell apoptosis by tryptophan catabolism. Cell Death Differ 2002; 9: 1069–1077.
    Article CAS Google Scholar
19. Meisel R, Zibert A, Laryea M, Gobel U, Daubener W, Dilloo D . Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase-mediated tryptophan degradation. Blood 2004; 103: 4619–4621.
    Article CAS Google Scholar
20. Munn DH, Zhou M, Attwood JT, Bondarev I, Conway SJ, Marshall B et al. Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 1998; 281: 1191–1193.
    Article CAS Google Scholar

Download references